Diagnostic value of risk of malignancy index in the clinical evaluation of ovarian mass

In the present study, the Risk Malignancy Index (RMI) was calculated based on menopausal status, ultrasound (US) findings and serum biological cancer antigen 125 (CA-125) levels as a scoring system in Libyan females with ovarian masses (OMs) to differentiate between benign and malignant tumors. A to...

Descripción completa

Detalles Bibliográficos
Autores principales: Huwidi, Ali, Abobrege, Afaf, Assidi, Mourad, Buhmeida, Abdelbaset, Ermiah, Eramah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204318/
https://www.ncbi.nlm.nih.gov/pubmed/35747594
http://dx.doi.org/10.3892/mco.2022.2551

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204318/
https://www.ncbi.nlm.nih.gov/pubmed/35747594
http://dx.doi.org/10.3892/mco.2022.2551

Ejemplares similares